(Q39962747)

15 September 2017

title

The Bcr-Abl kinase inhibitor INNO-406 induces autophagy and different modes of cell death execution in Bcr-Abl-positive leukemias (English)

1 reference

15 September 2017

0 references

1 reference

Y Kamitsuji

1

1 reference

15 September 2017

J Kuroda

2

1 reference

15 September 2017

S Kimura

3

1 reference

15 September 2017

S Toyokuni

4

1 reference

15 September 2017

K Watanabe

5

1 reference

15 September 2017

E Ashihara

6

1 reference

15 September 2017

H Tanaka

7

1 reference

15 September 2017

Y Yui

8

1 reference

15 September 2017

M Watanabe

9

1 reference

15 September 2017

H Matsubara

10

1 reference

15 September 2017

Y Mizushima

11

1 reference

15 September 2017

Y Hiraumi

12

1 reference

15 September 2017

E Kawata

13

1 reference

15 September 2017

T Yoshikawa

14

1 reference

15 September 2017

T Maekawa

15

1 reference

15 September 2017

T Nakahata

16

1 reference

15 September 2017

S Adachi

17

1 reference

15 September 2017

publication date

11 July 2008

1 reference

Cell Death & Differentiation

15 September 2017

published in

1 reference

15 September 2017

volume

15

1 reference

15 September 2017

issue

11

1 reference

15 September 2017

page(s)

1712-1722

1 reference

https://scigraph.springernature.com/pub.10.1038/cdd.2008.107

15 September 2017

exact match

0 references

cites work

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.107

Biology of chronic myelogenous leukemia--signaling pathways of initiation and transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.107

Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.107

New tyrosine kinase inhibitors in the treatment of chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.107

Bim and Bad mediate imatinib-induced killing of Bcr/Abl+ leukemic cells, and resistance due to their loss is overcome by a BH3 mimetic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.107

Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.107

A phase 2 study of imatinib in patients with relapsed or refractory Philadelphia chromosome-positive acute lymphoid leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.107

Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.107

NS-187, a potent and selective dual Bcr-Abl/Lyn tyrosine kinase inhibitor, is a novel agent for imatinib-resistant leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.107

The pathophysiology of mitochondrial cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.107

Caspase-independent programmed cell death with necrotic morphology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.107

Caspase-independent cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.107

Four deaths and a funeral: from caspases to alternative mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.107

A novel mechanism for imatinib mesylate-induced cell death of BCR-ABL-positive human leukemic cells: caspase-independent, necrosis-like programmed cell death mediated by serine protease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.107

Pathways of apoptotic and non-apoptotic death in tumour cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.107

BNIP3 and genetic control of necrosis-like cell death through the mitochondrial permeability transition pore

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.107

The anticancer drug imatinib induces cellular autophagy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.107

Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.107

Inhibition of macroautophagy triggers apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.107

Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.107

Another way to die: autophagic programmed cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.107

A matter of life or death (or both): understanding autophagy in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.107

LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.107

Growth factor regulation of autophagy and cell survival in the absence of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.107

CAD/DFF40 nuclease is dispensable for high molecular weight DNA cleavage and stage I chromatin condensation in apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.107

IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.107

Direct cleavage by the calcium-activated protease calpain can lead to inactivation of caspases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.107

Hydrogen peroxide inhibits caspase-dependent apoptosis by inactivating procaspase-9 in an iron-dependent manner.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.107

Apoptosis-based dual molecular targeting by INNO-406, a second-generation Bcr-Abl inhibitor, and ABT-737, an inhibitor of antiapoptotic Bcl-2 proteins, against Bcr-Abl-positive leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.107

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.107

Apoptosis initiated by Bcl-2-regulated caspase activation independently of the cytochrome c/Apaf-1/caspase-9 apoptosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.107

Apoptosis: a link between cancer genetics and chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.107

Recruitment, activation and retention of caspases-9 and -3 by Apaf-1 apoptosome and associated XIAP complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.107

Establishment and characterization of a novel imatinib-sensitive chronic myeloid leukemia cell line MYL, and an imatinib-resistant subline MYL-R showing overexpression of Lyn.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.107

Selective induction of apoptosis in Philadelphia chromosome-positive chronic myelogenous leukemia cells by an inhibitor of BCR–ABL tyrosine kinase, CGP 57148

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.107

inferred from DOI database lookup

7 January 2021

based on heuristic

p53-defective tumors with a functional apoptosome-mediated pathway: a new therapeutic target

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.107

inferred from DOI database lookup

7 January 2021

based on heuristic

Caspase-independent cell death in AML: caspase inhibition in vitro with pan-caspase inhibitors or in vivo by XIAP or Survivin does not affect cell survival or prognosis

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.107

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/CDD.2008.107

1 reference

15 September 2017

1 reference